Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia

• Status: Completed
• Trial end date: 2018-12-30
• Target enrollment: 0
• Participant gender: All

Summary

To compare intravenous levofloxacin and ciprofloxacin regarding their risk on the corrected QT interval (QTc) prolongation and dysglycemia in diabetic and non-diabetic patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beni-Suef University
• Treatments: Ciprofloxacin; Levofloxacin; Ofloxacin

Criteria

Inclusion Criteria:

• adult patient (male, female)

• age from 18 to 70 years .

• Be able to give an informed consent form after understanding for reasonable explanation of clinical trial's purpose, contents and characteristics of clinical drugs

• Wiling to participate whole clinical trial periods

Exclusion Criteria:

• Younger than 18 years or older than 70 years.

• Has prolonged QTc before receiving therapy.

• With a history of heart diseases.

• Received class IA or III antiarrhythmic agents.

• Received macrolide antibiotics.

• With a history of quinolone allergy.

• Pregnant and lactating women.